Splenectomy may facilitate systemic therapy for advanced hepatocellular carcinoma with hypersplenism.
作者信息
Zhang Er-Lei, Zhang Zun-Yi, Huang Zhi-Yong
机构信息
Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
出版信息
Hepatobiliary Surg Nutr. 2023 Feb 28;12(1):137-139. doi: 10.21037/hbsn-22-545. Epub 2023 Jan 16.
Abstract
摘要
相似文献
1
Splenectomy may facilitate systemic therapy for advanced hepatocellular carcinoma with hypersplenism.脾切除术可能有助于对伴有脾功能亢进的晚期肝细胞癌进行全身治疗。
Hepatobiliary Surg Nutr. 2023 Feb 28;12(1):137-139. doi: 10.21037/hbsn-22-545. Epub 2023 Jan 16.
2
Laparoscopic splenectomy may be a superior supportive intervention for cirrhotic patients with hypersplenism.腹腔镜脾切除术可能是治疗肝硬化伴脾功能亢进患者的一种更好的支持性干预措施。
J Gastroenterol Hepatol. 2010 Feb;25(2):397-402. doi: 10.1111/j.1440-1746.2009.06031.x. Epub 2009 Nov 19.
3
4
Hypersplenism is correlated with increased risk of hepatocellular carcinoma in patients with post-hepatitis cirrhosis.脾功能亢进与肝炎后肝硬化患者肝细胞癌风险增加相关。
Tumour Biol. 2016 Jul;37(7):8889-900. doi: 10.1007/s13277-015-4764-5. Epub 2016 Jan 11.
5
Use of hepatectomy and splenectomy to treat hepatocellular carcinoma with cirrhotic hypersplenism.使用肝切除术和脾切除术治疗伴有肝硬化脾功能亢进的肝细胞癌。
Br J Surg. 2005 Mar;92(3):334-9. doi: 10.1002/bjs.4776.
6
Simultaneous microwave coagulo-necrotic therapy (MCN) and laparoscopic splenectomy for the treatment of hepatocellular carcinoma with cirrhotic hypersplenism.同步微波凝固坏死疗法（MCN）联合腹腔镜脾切除术治疗肝硬化性脾功能亢进合并肝细胞癌
Surg Today. 2017 May;47(5):548-554. doi: 10.1007/s00595-016-1411-8. Epub 2016 Aug 30.
7
[Role of united hepatectomy and splenectomy in the surgical treatment of hepatocellular carcinoma complicated with hepatic cirrhosis and hypersplenism].联合肝切除术和脾切除术在肝细胞癌合并肝硬化及脾功能亢进外科治疗中的作用
Zhonghua Wai Ke Za Zhi. 2005 Apr 1;43(7):442-6.
8
Splenectomy before hepatectomy for patients with hepatocellular carcinoma and hypersplenism: A retrospective study.肝癌合并脾功能亢进患者行肝切除术前脾切除术：一项回顾性研究。
Medicine (Baltimore). 2021 Jan 29;100(4):e24326. doi: 10.1097/MD.0000000000024326.
9
Synchronous splenectomy and hepatectomy for patients with hepatocellular carcinoma and hypersplenism: A case-control study.肝细胞癌合并脾功能亢进患者同期脾切除与肝切除术：一项病例对照研究。
World J Gastroenterol. 2015 Feb 28;21(8):2358-66. doi: 10.3748/wjg.v21.i8.2358.
10
Simultaneous radiofrequency ablation combined with laparoscopic splenectomy: a safe and effective way for patients with hepatocellular carcinoma complicated with cirrhosis and hypersplenism.同步射频消融联合腹腔镜脾切除术：治疗肝细胞癌合并肝硬化及脾功能亢进患者的一种安全有效的方法。
Minim Invasive Ther Allied Technol. 2020 Jun;29(3):177-184. doi: 10.1080/13645706.2019.1609990. Epub 2019 May 22.
引用本文的文献
1
Revisiting the role of local treatments in the era of targeted therapy and immunotherapy for hepatocellular carcinoma.重新审视局部治疗在肝细胞癌靶向治疗和免疫治疗时代的作用。
World J Surg Oncol. 2025 Aug 27;23(1):323. doi: 10.1186/s12957-025-03963-3.
2
Preoperative high-precision three-dimensional reconstruction in laparoscopic splenectomy for supramassive splenomegaly: a case report and literature review.超大脾肿大腹腔镜脾切除术中的术前高精度三维重建：一例报告及文献复习
Front Med (Lausanne). 2025 Mar 5;12:1570335. doi: 10.3389/fmed.2025.1570335. eCollection 2025.
3
Development and validation of a prognostic nomogram including inflammatory indicators for overall survival in hepatocellular carcinoma patients treated primarily with surgery or loco-regional therapy: A single-center retrospective study.一项包含炎症指标的预测性列线图的开发与验证，用于主要接受手术或局部区域治疗的肝细胞癌患者的总生存：一项单中心回顾性研究
Medicine (Baltimore). 2024 Dec 13;103(50):e40889. doi: 10.1097/MD.0000000000040889.
4
Portal vein velocity predicts portal vein system thrombosis after splenectomy with esophagogastric devascularization.门脉流速可预测贲门周围血管离断术后门静脉系统血栓形成。
Surg Endosc. 2024 Feb;38(2):648-658. doi: 10.1007/s00464-023-10566-0. Epub 2023 Nov 27.
本文引用的文献
1
Deterioration of liver function and aging disturb sequential systemic therapy for unresectable hepatocellular carcinoma.肝功能恶化和衰老会干扰不可切除肝细胞癌的序贯系统治疗。
Sci Rep. 2022 Oct 11;12(1):17018. doi: 10.1038/s41598-022-21528-2.
2
Toxicity Profiles of Systemic Therapies for Advanced Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.晚期肝细胞癌系统治疗的毒性特征：系统评价和荟萃分析。
JAMA Netw Open. 2022 Jul 1;5(7):e2222721. doi: 10.1001/jamanetworkopen.2022.22721.
3
Lenvatinib plus pembrolizumab: the next frontier for the treatment of hepatocellular carcinoma?乐伐替尼联合帕博利珠单抗：肝癌治疗的下一个前沿？
Expert Opin Investig Drugs. 2022 Apr;31(4):371-378. doi: 10.1080/13543784.2021.1948532. Epub 2021 Jun 30.
4
Impact of splenomegaly and splenectomy on prognosis in hepatocellular carcinoma with portal vein tumor thrombus treated with hepatectomy.脾肿大和脾切除术对接受肝切除术治疗的伴有门静脉癌栓的肝细胞癌预后的影响。
Ann Transl Med. 2021 Feb;9(3):247. doi: 10.21037/atm-20-2229.
5
Hepatocellular Carcinoma.肝细胞癌
N Engl J Med. 2019 Apr 11;380(15):1450-1462. doi: 10.1056/NEJMra1713263.
6
Splenectomy suppresses growth and metastasis of hepatocellular carcinoma through decreasing myeloid-derived suppressor cells in vivo.脾切除术通过减少体内髓源性抑制细胞来抑制肝细胞癌的生长和转移。
J Huazhong Univ Sci Technolog Med Sci. 2016 Oct;36(5):667-676. doi: 10.1007/s11596-016-1643-2. Epub 2016 Oct 18.
7
Efficacy of splenectomy for hypersplenic patients with advanced hepatocellular carcinoma.脾切除术治疗晚期肝细胞癌伴脾功能亢进患者的疗效。
Hepatol Res. 2008 Dec;38(12):1172-7. doi: 10.1111/j.1872-034X.2008.00389.x. Epub 2008 Jul 4.
8
Use of hepatectomy and splenectomy to treat hepatocellular carcinoma with cirrhotic hypersplenism.使用肝切除术和脾切除术治疗伴有肝硬化脾功能亢进的肝细胞癌。
Br J Surg. 2005 Mar;92(3):334-9. doi: 10.1002/bjs.4776.
Zotero 插件